首页 | 本学科首页   官方微博 | 高级检索  
检索        

参麦注射液对充血性心力衰竭的疗效观察
引用本文:柳志红,程显声,张朝阳,赵彦芬,何建国,张云,倪新海,陈白屏.参麦注射液对充血性心力衰竭的疗效观察[J].中国中西医结合杂志,1998,18(4):212-213.
作者姓名:柳志红  程显声  张朝阳  赵彦芬  何建国  张云  倪新海  陈白屏
作者单位:中国医学科学院
摘    要:目的:观察参麦注射液对充血性心力衰竭患者的临床疗效。方法:应用随机交叉对比的方法,对16例慢性充血性心力衰竭进行参麦注射液和门冬氨酶钾镁治疗比较。结果:应用参麦注射液2周后,左室射血分数由29.5±9.0升至36.6±10.2,68.75%的患者心功能改善,未发现明显毒副作用;阂冬氨酸钾镁可使37.50%的患者心功能改善,但左室身因分数无明显变化。结论:参麦注射液是治疗充血性心力竭的有效药物。

关 键 词:充血性心力衰竭  参麦注射液  心功能

Observation on Effect of Shenmai Injection in Treating Patients of Congestive Heart Failure
Authors:Liu Zhihong  Cheng Xiansheng  Zhang Chaoyang  Division of Cardio Pulmonary Circulation Fuwai Hospital  Chinese Academy of Medical Sciences  Beijing
Institution:Division of Cardio-Pulmonary Circulation Funai Hospital, Chinese Academy of Medical Sciences, Beijing 100037.
Abstract:OBJECTIVE: To observe the clinical therapeutic effect of Shenmai Injection (SMI) in treating patients of congestive heart failure. METHODS: Effect of 16 cases treated with SMI or potassium magnesium aspartate was observed by randomized crossover method and compared. RESULTS: By using SMI for 2 weeks, patients' left ventricular ejective fraction (LVEF) could be increased from 29.5 +/- 9.0 to 36.6 +/- 10.2 (P < 0.05), the heart function of 68.75% patients was improved, no side effects or toxicity was observed. Potassium magnesium asparate could improve heart function in 37.50% patients only but with no effect on LVEF. CONCLUSION: SMI is an effective and safe therapy in treating patients with congestive heart failure.
Keywords:congestive heart failure  Shenmai Injection  heart function
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号